Sana Biotechnology (SANA) Accumulated Depreciation (2020 - 2026)

Sana Biotechnology has reported Accumulated Depreciation for 7 years, with the latest figure at $57.1 million in Q1 2026.

• Quarterly Accumulated Depreciation changed 0.33% year-over-year to $57.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.1 million (changed 0.33% YoY) and the FY2025 annual result came in at $54.8 million, up 1.09% from the prior year.
• Accumulated Depreciation climbed to $57.1 million in Q1 2026 per SANA's latest filing, from $54.8 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $57.3 million in Q1 2025 and troughed at $22.4 million in Q1 2022.
• A 5-year average of $44.7 million and a median of $47.3 million in 2023 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2022 and 2026: Accumulated Depreciation jumped 124.24% in 2022, then retreated 0.33% in 2026.
• Over 5 years, Accumulated Depreciation stood at $34.0 million in 2022, then grew by 22.94% to $41.8 million in 2023, then increased by 29.67% to $54.2 million in 2024, then climbed by 1.09% to $54.8 million in 2025, then gained by 4.37% to $57.1 million in 2026.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $57.1 million, $54.8 million, and $53.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.